Clinical Trial Update: High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing high-dose ribavirin with peginterferon for chronic hepatitis C genotype 1; the study completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-09-16